Home > Publications >Anti-SSTR2 Antibody-Drug Conjugate for Neuroendocrine Cancer Therapy >

<<Previous Next>>

Post Date:Feb-08-22

Anti-SSTR2 Antibody-Drug Conjugate for Neuroendocrine Cancer Therapy

AcceGenAuthor: AcceGen R&D Team

Date Published: 08-Feb-22

Anti-SSTR2 Antibody-Drug Conjugate for Neuroendocrine Cancer Therapy

  • Authors: Yingnan Si, Seulhee Kim, Jianfa Ou, Yun Lu, Patrick Ernst, Kai Chen, Jason Whitt, Angela M. Carter, James M. Markert, James A. Bibb, Herbert Chen, Lufang Zhou, Renata Jaskula-Sztul & Xiaoguang “Margaret” Liu
  • Journal: Cancer Gene Therapy
  • DOI: 10.1038/s41417-020-0196-5
  • Cited AcceGen Product/Service: QGP-1

<<Previous Next>>

AcceGen Scroll Top Button